Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Recruiting 8Unknown 7Completed 6Not yet recruiting 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 8NETWORK 1

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Breast 2Thoracic 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thymoma 1Neoplastic Cells, Circulating 1Neoplasms 1Esophageal Neoplasms 1Carcinoma, Lobular 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Recruiting × OTHER × Radiotherapy, Adjuvant × Clear all
NCT07613151 2026-05-29

NAPOLI

Istituto Oncologico Veneto IRCCS

Recruiting
250 enrolled

Neoplasms, Carcinoma, Lobular

NCT06897488 2026-05-15

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

M.D. Anderson Cancer Center

Phase 2 Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT02633553 2026-04-24

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Fudan University

Phase NA Recruiting
238 enrolled
Thoracic

Thymoma

NCT06524167 2026-02-27

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Fudan University

Recruiting
80 enrolled
Head & Neck

Thyroid Neoplasms

NCT06914440 2025-07-15

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Xijing Hospital

Phase 2 Recruiting
27 enrolled
Breast

Breast Neoplasms

NCT06272214 2024-07-16

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Zhejiang Cancer Hospital

Phase 2 Recruiting
146 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT04902937 2023-11-28

CETC

University of Jena

Recruiting
200 enrolled

Neoplastic Cells, Circulating

NCT04989647 2023-09-07

CERVANTES

The Central and Eastern European Gynecologic Oncology Group

Phase 3 Recruiting
514 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡